Pharmaceutical Preparations · CA · CIK 874015
IONIS PHARMACEUTICALS INC invents RNA-targeted medicines to treat serious diseases
Comparable business profile · signals at a glance
In the 90 days to Mar 19, 2026: 15 sold $82.8M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 19, 2026 | Schneider EugeneEVP, Chf Clinical Develop Ofcr | Sell | 5,812 | $70.97 | $412K |
| Mar 17, 2026 | Hougen Elizabeth LEVP, Finance & CFO | Sell | 10,172 | $73.21 | $745K |
| Mar 16, 2026 | Hougen Elizabeth LEVP, Finance & CFO | Sell | 205,608 | $72.38 | $14.9M |
| Mar 16, 2026 | Hougen Elizabeth LEVP, Finance & CFO | Sell | 9,440 | $72.77 | $687K |
| Mar 10, 2026 | Jenne KyleEVP, Chf GL Pdt Str Ofcr | Sell | 21,191 | $75.50 | $1.6M |
| Mar 10, 2026 | Monia Brett PChief Executive Officer | Sell | 17,591 | $76.34 | $1.3M |
| Mar 10, 2026 | Monia Brett PChief Executive Officer | Sell | 16,512 | $75.47 | $1.2M |
| Mar 10, 2026 | Jenne KyleEVP, Chf GL Pdt Str Ofcr | Sell | 16,086 | $76.30 | $1.2M |
| Mar 9, 2026 | Monia Brett PChief Executive Officer | Sell | 117,604 | $75.26 | $8.9M |
| Mar 9, 2026 | O'Neil Patrick R.EVP CLO & General Counsel | Sell | 10,148 | $75.25 | $764K |
| Mar 9, 2026 | Monia Brett PChief Executive Officer | Sell | 7,382 | $74.11 | $547K |
| Mar 9, 2026 | Monia Brett PChief Executive Officer | Sell | 1,684 | $75.58 | $127K |
| Mar 4, 2026 | Baroldi JosephEVP, Chief Business Officer | Sell | 238 | $80.00 | $19K |
| Mar 4, 2026 | Baroldi JosephEVP, Chief Business Officer | Sell | 201 | $80.00 | $16K |
| Mar 4, 2026 | Loscalzo JosephDirector | Sell | 200 | $80.00 | $16K |
| Mar 3, 2026 | Bennett C FrankEVP, Chief Scientific Officer | Sell | 71,600 | $79.10 | $5.7M |
| Mar 3, 2026 | Diaz Allene M.Director | Sell | 39,265 | $79.11 | $3.1M |
| Mar 3, 2026 | Diaz Allene M.Director | Sell | 14,608 | $79.88 | $1.2M |
| Mar 3, 2026 | Devers Shannon L.EVP, Chief Human Resources Ofc | Sell | 14,321 | $79.12 | $1.1M |
| Mar 3, 2026 | Klein Joseph IiiDirector | Sell | 13,526 | $79.17 | $1.1M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.